Axonics Past Earnings Performance

Past criteria checks 0/6

Axonics has been growing earnings at an average annual rate of 21.7%, while the Medical Equipment industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 44.7% per year.

Key information

21.7%

Earnings growth rate

34.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate44.7%
Return on equity-0.3%
Net Margin-0.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

A Look At The Fair Value Of Axonics, Inc. (NASDAQ:AXNX)

Jul 14
A Look At The Fair Value Of Axonics, Inc. (NASDAQ:AXNX)

Axonics, Inc.'s (NASDAQ:AXNX) Earnings Haven't Escaped The Attention Of Investors

Jun 20
Axonics, Inc.'s (NASDAQ:AXNX) Earnings Haven't Escaped The Attention Of Investors

Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 21% Discount?

Mar 27
Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 21% Discount?

Here's Why We're Not At All Concerned With Axonics' (NASDAQ:AXNX) Cash Burn Situation

Feb 28
Here's Why We're Not At All Concerned With Axonics' (NASDAQ:AXNX) Cash Burn Situation

Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 32% Discount?

Nov 28
Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 32% Discount?

Axonics stock falls 5.6% after Needham downgrades rating

Oct 10

Axonics Stock Is A Buy Amid Current Capex Cycle

Sep 07

Axonics prices stock offering of 1.75M shares

Aug 03

Companies Like Axonics (NASDAQ:AXNX) Can Afford To Invest In Growth

Aug 02
Companies Like Axonics (NASDAQ:AXNX) Can Afford To Invest In Growth

Axonics: A Strong Medical Device Play With Significant Revenue Growth Opportunities

May 30

Axonics (NASDAQ:AXNX) Is In A Strong Position To Grow Its Business

Apr 19
Axonics (NASDAQ:AXNX) Is In A Strong Position To Grow Its Business

We're Hopeful That Axonics (NASDAQ:AXNX) Will Use Its Cash Wisely

Sep 15
We're Hopeful That Axonics (NASDAQ:AXNX) Will Use Its Cash Wisely

Revenue & Expenses Breakdown

How Axonics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:AXNX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24409-226542
31 Mar 24387-1625238
31 Dec 23366-623535
30 Sep 23343-1222333
30 Jun 23320-3221333
31 Mar 23296-4620831
31 Dec 22274-6019634
30 Sep 22241-7618136
30 Jun 22217-7716837
31 Mar 22194-8015139
31 Dec 21180-8013637
30 Sep 21162-7612135
30 Jun 21150-6810934
31 Mar 21120-639532
31 Dec 20112-559229
30 Sep 2087-668927
30 Jun 2053-828724
31 Mar 2039-818223
31 Dec 1914-806820
30 Sep 194-675119
30 Jun 193-493418
31 Mar 192-392119
31 Dec 181-321319
30 Sep 180-281018
30 Jun 180-25717
31 Mar 180-20614
31 Dec 170-18612

Quality Earnings: AXNX is currently unprofitable.

Growing Profit Margin: AXNX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AXNX is unprofitable, but has reduced losses over the past 5 years at a rate of 21.7% per year.

Accelerating Growth: Unable to compare AXNX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AXNX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.5%).


Return on Equity

High ROE: AXNX has a negative Return on Equity (-0.27%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies